Skip to main content
Download PDF
  • Article selection
  • Published:

Articles selected in February 2004

Breast Cancer Research volume 6, Article number: E12 (2004) Cite this article

Articles selected from PubMed

References

  1. Wang LH, Yang XY, Zhang X, Mihalic K, Fan YX, Xiao W, Howard OM, Appella E, Maynard AT, Farrar WL: Suppression of breast cancer by chemical modulation of vulnerable zinc fingers in estrogen receptor. Nat Med. 2004, 10: 40-47.

    Article  CAS  PubMed  Google Scholar 

  2. Santen RJ, Song RX, Zhang Z, Yue W, Kumar R: Adaptive hypersensitivity to estrogen: mechanism for sequential responses to hormonal therapy in breast cancer. Clin Cancer Res. 2004, 10: 337-345.

    Article  Google Scholar 

  3. Nicholson RI, Hutcheson IR, Knowlden JM, Jones HE, Harper ME, Jordan N, Hiscox SE, Barrow D, Gee JM: Nonendocrine pathways and endocrine resistance: observations with antiestrogens and signal transduction inhibitors in combination. Clin Cancer Res. 2004, 10: 346-354.

    Article  Google Scholar 

  4. Strom A, Hartman J, Foster JS, Kietz S, Wimalasena J, Gustafsson JA: Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D. Proc Natl Acad Sci USA. 2004, 101: 1566-1571.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Hoffmann J, Bohlmann R, Heinrich N, Hofmeister H, Kroll J, Kunzer H, Lichtner RB, Nishino Y, Parczyk K, Sauer G, Gieschen H, Ulbrich HF, Schneider MR: Characterization of New Estrogen Receptor Destabilizing Compounds: Effects on Estrogen-Sensitive and Tamoxifen-Resistant Breast Cancer. J Natl Cancer Inst. 2004, 96: 210-218.

    Article  CAS  PubMed  Google Scholar 

  6. Holmberg L, Anderson H, for the HABITS steering and data monitoring committees: HABITS (hormonal replacement therapy after breast cancer – is it safe?), a randomised comparison: trial stopped. The Lancet. 2004, 363: 453-455.

    Article  CAS  Google Scholar 

  7. Balasenthil S, Sahin AA, Barnes CJ, Wang RA, Pestell RG, Vadlamudi RK, Kumar R: p21-activated Kinase-1 Signaling Mediates Cyclin D1 Expression in Mammary Epithelial and Cancer Cells. J Biol Chem. 2004, 279: 1422-1428.

    Article  CAS  PubMed  Google Scholar 

  8. Reiter R, Oh AS, Wellstein A, Riegel AT: Impact of the nuclear receptor coactivator AIB1 isoform AIB1-Delta 3 on estrogenic ligands with different intrinsic activity. Oncogene. 2004, 23: 403-409.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Molecular Medicine Unit, University of Leeds, St James's University Hospital, Leeds, LS9 7TF, UK

    Valerie Speirs

Authors
  1. Valerie Speirs
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Valerie Speirs.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Speirs, V. Articles selected in February 2004 . Breast Cancer Res 6, E12 (2004). https://doi.org/10.1186/bcr769

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/bcr769

Keywords

Breast Cancer Research

ISSN: 1465-542X

Contact us